KO-MED Centra Kliniczne
KO-MED Centra Kliniczne is a Poland-based network of clinical research centers, founded in 1999, that conducts clinical trials and supporting research for pharmaceutical and biotech sponsors across Poland.
- Company typePrivate
- Founded1999
- HeadquartersPulawy, Poland
- Headcount101–250
- GTM typeB2B
- OfferingServices
What KO-MED Centra Kliniczne does
KO-MED Centra Kliniczne is a Poland-based, privately held operator of a network of clinical trial research centers. Founded in 1999 by Marek Konieczny, who continues to serve as chairman of the board, the company is headquartered in Pulawy and conducts clinical research projects across multiple sites throughout Poland, serving the pharmaceutical and biotech industry as its primary customer segment. Its functional role is that of a multi-site clinical trial operator (site network) rather than a full-service contract research organization, providing the physical infrastructure, investigators, and patient-recruitment footprint that sponsors rely on to execute late-stage clinical studies within the Polish healthcare system.
The company's service offering, based on available data, is concentrated on the operational conduct of clinical trials and supporting research for new drugs, therapies, and medical devices — no distinct branded product lines, technology platforms, or digital tools are identified in the source material. Headcount is reported at 101–250 employees, consistent with a mid-sized multi-site operator. KO-MED's geographic scope is explicitly national (Poland), and its marketing, distribution, and pricing details are not disclosed in the available data. No named sponsor customers, partnerships, certifications, patents, or regulatory actions are documented in the input.
Commercially, the company operates as a fee-for-service site network generating revenue from pharmaceutical and biotech sponsors that contract its centers for protocol execution, patient recruitment, and clinical data collection. However, the input contains no disclosed revenue, funding history, ownership structure, or financial detail of any kind, and no information on senior management beyond the founder/chairman. As a result, the financial scale, growth dynamics, and competitive positioning of the business cannot be quantified from the source data — only the structural facts of a 25-year-old, mid-sized, domestically focused Polish clinical site network are supported.
KO-MED Centra Kliniczne firmographics
Firmographics- Name
- KO-MED Centra Kliniczne
- Website
- https://komed-ck.pl
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- KO-MED Centra Kliniczne is a Poland-based network of clinical research centers, founded in 1999, that conducts clinical trials and supporting research for pharmaceutical and biotech sponsors across Poland.
- Ownership category
- akta.pro rank
KO-MED Centra Kliniczne industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industry
- Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)
Keywords
Where KO-MED Centra Kliniczne is headquartered
LocationHeadquarters
- HQ city
- Pulawy
- HQ country
- Poland
- HQ region
- Europe
Markets served
KO-MED Centra Kliniczne business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
KO-MED Centra Kliniczne product offering
Product offeringCore offering
KO-MED Centra Kliniczne operates a network of modern research centers across Poland that conduct clinical research projects for pharmaceutical, biotechnology, and medical device sponsors. The company's service is the clinical trial itself—patient recruitment, study execution, and research site operations across multiple Polish locations. The fundamental activity is operating physical clinical research sites and managing clinical projects within Poland rather than developing a software or digital platform.
Product overview
KO-MED Centra Kliniczne is a network of modern research centers conducting clinical research projects across Poland. Based on the limited source data available, no specific named products, modules, or distinct service offerings were identified in the provided content.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical research projects across a network of Polish research centers End-to-end clinical research project execution delivered through KO-MED's network of modern research centers in Poland, supporting pharmaceutical, biotechnology, and medical device sponsors with site-based clinical trial operations across the country.
Companies that use KO-MED Centra Kliniczne
Customer profileSegments1 record
Ideal customer profiles1 record
KO-MED Centra Kliniczne technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
KO-MED Centra Kliniczne partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
KO-MED Centra Kliniczne competitors and assessment
Company assessmentBroad incumbents
- Parexel International: Global CRO providing biopharmaceutical clinical trial services including site operations. Comparable to KO-MED in clinical research service delivery for pharma sponsors, though at much larger scale.
- Syneos Health: Global clinical and commercial solutions provider including site management and clinical trial services. Comparable in delivering clinical research services to pharma/biotech sponsors alongside site operations.
- Medpace: Mid-sized global CRO with full-service clinical trial delivery including site management. Comparable to KO-MED in clinical-trial execution for pharma/biotech sponsors.
- IQVIA: World's largest clinical research services provider with global site network and full-service CRO capabilities. Comparable as a clinical trial site/services competitor serving the same pharma sponsor base as KO-MED.
- ICON plc: Global CRO running site operations, monitoring, and full-service clinical research across all major regions. Comparable to KO-MED as a clinical-trial service provider to pharma/biotech sponsors, though operating at much broader scale.
Direct peers
- Velocity Clinical Research: Multi-site clinical research site network operating dedicated research centers across the US and internationally. Closely comparable to KO-MED's operating model of networked modern research centers running clinical trials.
- KCR: Polish-headquartered clinical research organization providing CRO and site-support services across the CEE region. Comparable to KO-MED as a Poland-rooted clinical research operator targeting pharmaceutical/biotech sponsors.
- CenExel: US-focused clinical research site network with multiple dedicated research centers. Comparable to KO-MED as a network model of dedicated research centers running trials for pharma sponsors.
- Clinmark: Polish/EEA clinical research and pharma services provider. Comparable to KO-MED in operating clinical research infrastructure for pharma sponsors within the Polish and broader CEE market.
Regional players
- SMO/contract research site operators in Poland (e.g., NZOZ Pró-Familia, clinical site networks): Polish clinical/diagnostic site operators that also participate in clinical trials in Poland. Comparable to KO-MED as Polish regional site providers competing for the same sponsor-placed studies domestically.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
KO-MED Centra Kliniczne social profiles
Digital presenceKO-MED Centra Kliniczne financial estimates
Financial estimateRevenue estimate
Valuation estimate
KO-MED Centra Kliniczne leadership team
Management profileNumber of profiles
Profiles1 record
KO-MED Centra Kliniczne funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KO-MED Centra Kliniczne M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KO-MED Centra Kliniczne
What does KO-MED Centra Kliniczne do?
KO-MED Centra Kliniczne operates a network of modern research centers across Poland that conduct clinical research projects for pharmaceutical, biotechnology, and medical device sponsors. The company's service is the clinical trial itself—patient recruitment, study execution, and research site operations across multiple Polish locations. The fundamental activity is operating physical clinical research sites and managing clinical projects within Poland rather than developing a software or digital platform.
When was KO-MED Centra Kliniczne founded?
KO-MED Centra Kliniczne was founded in 1999. It employs 101 to 250 people.
Where is KO-MED Centra Kliniczne based?
KO-MED Centra Kliniczne is headquartered in Pulawy, Poland, in the Europe region.
Who are KO-MED Centra Kliniczne's main competitors?
Broad incumbents on record are Parexel International, Syneos Health, Medpace, IQVIA and ICON plc. Direct peers are Velocity Clinical Research, KCR, CenExel and Clinmark. SMO/contract research site operators in Poland (e.g., NZOZ Pró-Familia, clinical site networks) is listed as a regional player.
Does KO-MED Centra Kliniczne have an API?
No public API is recorded for KO-MED Centra Kliniczne.
What industry is KO-MED Centra Kliniczne in?
KO-MED Centra Kliniczne's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5417 and its SIC code is 8731.